Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1995
03/02/1995WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995WO1995005750A1 Cell death regulator
03/02/1995WO1995003418A3 Recombinant bcg vaccines
03/02/1995WO1995003414A3 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
03/02/1995WO1995003410A3 Guanylatcyclase activating peptide i (gcap-i) coding gene
03/02/1995WO1994028726A3 Method of treating retained pulmonary secretions
03/02/1995WO1994025601A3 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/02/1995DE4425481A1 Melanoma-inhibiting protein
03/02/1995DE4407859C1 Vector for liver-specific gene therapy
03/02/1995CA2170504A1 Compositions and methods for the administration of u-aminolevulinic acid
03/02/1995CA2170357A1 Method for producing a highly enriched population of hematopoietic stem cells
03/02/1995CA2170356A1 Recombinant cladosporium herbarum allergens
03/02/1995CA2170355A1 Recombinant alternaria alternata allergenes
03/02/1995CA2170352A1 Natural killer cell-specific antigen and antibodies that identify the same
03/02/1995CA2170159A1 Recombinant cells from the monocyte-macrophage cell ligne for gene therapy
03/02/1995CA2170158A1 Inhibitors of tnf-alpha secretion
03/02/1995CA2169945A1 Factor for fibroblast colony forming unit
03/02/1995CA2169941A1 Expression control sequences of the p-selectin gene
03/02/1995CA2169851A1 Cytokines that bind the cell surface receptor hek
03/02/1995CA2169849A1 Accessory factor function for interferon gamma and its receptor
03/02/1995CA2169748A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
03/02/1995CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995CA2169072A1 Novel tripeptides useful in immune and cns therapy
03/02/1995CA2167691A1 Campylobacter jejuni antigens, and methods for their production and use
03/01/1995EP0640689A2 p40 Homodimer of interleukin-12
03/01/1995EP0640688A1 Ribozymes
03/01/1995EP0640686A2 Method for stabilizing glucose 6-phosphate dehydrogenase
03/01/1995EP0640620A2 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic esterase receptor protein
03/01/1995EP0640619A1 Erythropoietin analogs with additional glycosylation sites
03/01/1995EP0640618A1 Tetrahydronaphthalene-peptide derivatives
03/01/1995EP0640336A1 Parenteral sustained releasable preparations comprising polyglycerol diesters
03/01/1995EP0640143A1 Senescent cell derived inhibitors of dna synthesis
03/01/1995EP0640131A1 Genetically engineered antibodies
03/01/1995EP0640130A1 Chimeric multivalent protein analogues and methods of use thereof
03/01/1995EP0640129A1 Inhibition of cell adhesion protein-carbohydrate interactions
03/01/1995EP0640101A1 Methods and reagents for diagnosis of autoantibodies
03/01/1995EP0640100A1 Modulation of thrombospondin-cd36 interactions
03/01/1995EP0640099A1 Peptides having tachykinin antagonist activity
03/01/1995EP0640097A1 Compositions and methods for vaccination against coronaviruses
03/01/1995EP0640096A1 Universal coronavirus vaccine
03/01/1995EP0640095A1 Process for making vancomycin
03/01/1995EP0640086A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO 1,2]PYRIDAZINE, PYRAZOLO 1,2]PYRIDAZINE, PYRIDAZO 1,2-a] 1,2]DIAZEPINE AND PYRAZOLO 1,2-a] 1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
03/01/1995EP0639984A1 Lyophilized somatotropin formulations
03/01/1995EP0639983A1 Antiviral agent comprising cd4 and an h2 histone
03/01/1995EP0639982A1 Use of mmp inhibitors
03/01/1995EP0639981A1 Igf-1 analogs
03/01/1995EP0639980A1 Use of platelet derived growth factor in ophthalmic wound healing
03/01/1995EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
03/01/1995EP0639977A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
03/01/1995EP0587797B1 Disinfecting shampoo composition for animals
03/01/1995EP0518908B1 Method for polymerization of epoxide compounds
03/01/1995EP0485491B1 Artificial biological membrane
03/01/1995EP0406428B1 Peptide derivatives and their use
03/01/1995CN1099415A Snail bioenzyme and snail biotin
03/01/1995CN1099392A Compounds containing a fused bicyclic ring and processes therefor
02/1995
02/28/1995US5393873 Peptides with anticoagulant activity
02/28/1995US5393870 Analogs of human granulocyte-macrophage colony stimulating factor
02/28/1995US5393869 Polypeptides; hormone therapy for osteoporosis, hypertension and hypoparathyroidism
02/28/1995US5393792 High dosage topical forms of collagenase
02/28/1995US5393740 Neurotensin Hexapeptides
02/28/1995US5393739 Use of bone morphogenetic protein in synergistic combination with TGF-β for bone repair
02/28/1995US5393738 Pharmaceutical compositions containing octreotide and excipients for oral or rectal administration
02/28/1995US5393737 Cytotoxic drug conjugates for treatment of neoplastic diseases
02/28/1995US5393667 Cause production of cyclic adenosine diphosphate ribose from nicotinamide adenine dinucleotide
02/28/1995US5393534 Liver-derived tumor cell growth inhibitor
02/28/1995US5393531 Effervescent, disintegrating mixture of drugs in one tablet; treating hypertension, osteoporosis, allergies
02/28/1995CA2028560C Methods and compositions employing certain lysozymes and endoglycosidases
02/28/1995CA1334589C Benzodiazepine derivatives
02/27/1995CA2130868A1 Sustained releasable parenteral pharmaceutical preparations and method of producing the same
02/27/1995CA2130793A1 Heterocyclic thrombin inhibitors
02/27/1995CA2130705A1 Method for stabilizing glucose 6-phosphate dehydrogenase
02/26/1995CA2130025A1 Method of treating fungal infections
02/24/1995CA2130230A1 Sugar-modified interferon
02/23/1995WO1995005600A1 Methods of detecting and combating disorders of the central nervous system
02/23/1995WO1995005478A1 Human timp-3
02/23/1995WO1995005470A1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor
02/23/1995WO1995005469A1 Human erythropoietin receptor fragment and antibodies thereto
02/23/1995WO1995005468A1 Binding molecules containing at least an immunoglobulin constant domain with modified allotypic determinant
02/23/1995WO1995005465A1 Erythropoietin analogs
02/23/1995WO1995005463A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells
02/23/1995WO1995005456A1 Pharmaceutical composition comprising phosphatase or a derivative thereof
02/23/1995WO1995005455A1 Pharmaceutical composition comprising phosphatase or a derivative thereof
02/23/1995WO1995005452A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
02/23/1995WO1995005397A1 Composition and methods using nitroxides to avoid oxygen toxicity
02/23/1995WO1995005394A1 Therapeutic and diagnostic agents for amyloidosis
02/23/1995WO1995005393A2 Lipopolysaccharide-binding and neutralizing peptides
02/23/1995WO1995005392A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences
02/23/1995WO1995005201A1 Adenoviruses having modified fiber proteins
02/23/1995WO1995005196A1 Antibody-based treatment of hiv infection
02/23/1995WO1995005195A1 Pharmaceutical immunoadjuvant or immunostimulating compositions
02/23/1995WO1995005192A1 SUBSTITUTED KETONE DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
02/23/1995WO1995005191A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-β ACTIVITY
02/23/1995WO1995005190A1 Method of inhibiting kaposi's sarcoma
02/23/1995WO1995005189A1 Class i mhc modulation of surface receptor activity
02/23/1995WO1995005188A1 Erection-inducing methods and compositions
02/23/1995WO1995005187A1 Hepatoselective pharmaceutical actives
02/23/1995WO1995005186A1 Ruthenium red as an inhibitor of the immune response
02/23/1995WO1995005167A2 Treatment of adverse effects associated with administration of extracellular hemoglobin
02/23/1995WO1995005078A1 Submicron emulsions for delivery of peptides
02/23/1995WO1995001420A3 A method of producing a protein disulfide redox agent
1 ... 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 2874 2875 2876 2877 2878 ... 3163